Intec Pharma has again tapped the Michael J. Fox Foundation for Parkinson’s Research for development of its Parkinson’s med AP-CD/LD.
A predictive model could help clinicians decide whether prostate cancer patients should be offered standard treatment or the chance to enter a clinical trial.
Eyeing the fast-growing medical device outsourcing market, CSSi has relaunched that arm of its business as a fully integrated CRO division.
Spanish CRO Kymos has closed a deal to acquire Italy's Pharmaprogress as part of an ongoing expansion in the European market.
Less than two months after the gigantic QuintilesIMS officially came into being, the newly merged company has snapped up the clinical trials division of TKL…
BenevolentAI's ambition to use artificial intelligence to revolutionize the drug development process is one step closer after a deal with Janssen.
The EMA has updated its guidance on first-in-human clinical trials in light of a fatality in a French study earlier this year.
Parexel says new software could help biopharma companies meet the looming EMA deadline for adopting Identification of Medicinal Products standards.
Emas Pharma, a CRO that provides biopharma and medical device services, has been bought by outsourced specialist Bionica and joined the latter’s existing…
Induced pluripotent stem cell (iPSC) specialist Axiogenesis AG has partnered with ion channel CRO Metrion Biosciences to develop human iPSC-derived…